[AVTE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -10.68%
YoY- -110.61%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -19,025 -16,520 -14,997 -13,588 -11,991 -10,910 -8,220 75.24%
Tax -1,312 -1,119 25 -564 -224 -109 3 -
NP -19,025 -15,401 -15,022 -13,024 -11,767 -10,801 -8,223 75.19%
Tax Rate - - - - - - - -
Total Cost 19,025 15,401 15,022 13,024 11,767 10,801 8,223 75.19%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.76 -0.62 -0.61 -0.53 -0.48 -0.44 -0.34 71.21%
EPS Diluted -0.76 -0.62 -0.61 -0.53 -0.48 -0.44 -0.34 71.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.